Seven Gülseren, Çınar Kubilay, Idilman Ramazan, Tüzüner Acar, Hazinedaroğlu Selçuk, Karayalçın Selim, Bahar Kadir
Department of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Turkey.
Turk J Gastroenterol. 2014 Apr;25(2):156-61. doi: 10.5152/tjg.2014.4055.
BACKGROUND/AIMS: The aims of the present study were to review biliary complications following liver transplantation in a single-center experience, to identify the factors associated with biliary complications, and to evaluate the success of endoscopic and percutaneous treatment in such patients.
Between January 1994 and June 2010, a total of 176 patients with liver disease underwent liver transplantation; 119 recipients were included in this retrospective analysis. Median posttransplant follow-up period was 49 months.
Mean age was 43.0±12.7 years. Living donor liver transplantation (LDLT) and deceased-donor liver transplantation (DDLT) were performed in 71 and 48 patients, respectively. Duct-to-duct anastomosis and Roux-en-Y hepaticojejunostomy were performed in 68 and 51 patients, respectively. The overall incidence of posttransplant biliary complications was 36%; anastomotic biliary strictures were the most common biliary complications (42%), followed by biliary leakage (28%). On logistic regression analysis, duct-duct anastomosis was the only risk factor associated with the development of biliary complications (Odds ratio (OR), 3.346; p=0.005). Endoscopic and percutaneous treatment was successful in the majority of patients (81%), and the remaining 19% recipients underwent surgery for biliary repair. Endoscopic retrograde cholangiopancreatography (ERCP) guided drainage and balloon dilatation with stent placement were the most common treatment modalities.
Biliary complications were most frequent after liver transplantation; biliary strictures were the most commonly seen. The use of duct-to-duct anastomosis for biliary reconstruction is a risk factor for the development of biliary complications. Endoscopic and percutaneous treatment was successful in the majority of these patients.
背景/目的:本研究旨在回顾单中心肝移植术后的胆道并发症,确定与胆道并发症相关的因素,并评估此类患者内镜及经皮治疗的成功率。
1994年1月至2010年6月,共有176例肝病患者接受了肝移植;本回顾性分析纳入了119例受者。移植后中位随访期为49个月。
平均年龄为43.0±12.7岁。71例和48例患者分别接受了活体供肝肝移植(LDLT)和尸体供肝肝移植(DDLT)。68例和51例患者分别进行了胆管对胆管吻合术和Roux-en-Y肝空肠吻合术。移植后胆道并发症的总发生率为36%;吻合口胆管狭窄是最常见的胆道并发症(42%),其次是胆漏(28%)。逻辑回归分析显示,胆管对胆管吻合术是与胆道并发症发生相关的唯一危险因素(比值比(OR),3.346;p=0.005)。大多数患者(81%)的内镜及经皮治疗取得成功,其余19%的受者接受了胆道修复手术。内镜逆行胰胆管造影(ERCP)引导下引流及球囊扩张并置入支架是最常见的治疗方式。
肝移植术后胆道并发症最为常见;胆管狭窄最为多见。采用胆管对胆管吻合术进行胆道重建是发生胆道并发症的危险因素。大多数此类患者的内镜及经皮治疗取得成功。